New study shows significant improved clinical accuracy with Nevisense for both US and German dermatologists

STOCKHOLM, Feb. 21, 2025 /PRNewswire/ — SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today, that an article comparing US and German dermatologists improved biopsy decisions following the addition of…